Orbital involvement in chronic lymphocytic leukemia: Case report
Abstract
Background: Orbital involvement in chronic lymphocytic leukemia is extremely rare. Accumulation of leukaemic cells, haemorrhagia or ischemic changes may include the eyeball or the surrounding tissues, causing permanent loss of vision. Advanced chronic lymphocytic leukemia is successfully treated with rituximab.Patients and methods: A case of a 78-year old female with chronic lymphocytic leukemia, with extensive swelling and redness of the left eyelid, bulging eyeball and visual disturbances is reported. We demonstrated infiltration of leukaemic cells in the tissue of the orbit. After the treatment with rituximab clinical signs of eye disability have completely resolved. Conclusions: In patients with chronic lymphocytic leukemia, progression of the disease should be suspected at impairment of the eye and the surrounding tissues. Monotherapy with rituximab can be successful, which is indicated particularly in elderly patients.Downloads
The Author transfers to the Publisher (Zdravniški vestnik/Slovenian Medical Journal) all economic copyrights following form Article 22 of the Slovene Copyright and Related Rights Act (ZASP), including the right of reproduction, the right of distribution, the rental right, the right of public performance, the right of public transmission, the right of public communication by means of phonograms and videograms, the right of public presentation, the right of broadcasting, the right of rebroadcasting, the right of secondary broadcasting, the right of communication to the public, the right of transformation, the right of audiovisual adaptation and all other rights of the author according to ZASP.
The aforementioned rights are transferred non-exclusively, for an unlimited number of editions, for the term of the statutory
The Author can make use of his work himself or transfer subjective rights to others only after 3 months from date of first publishing in the journal Zdravniški vestnik/Slovenian Medical Journal.
The Publisher (Zdravniški vestnik/Slovenian Medical Journal) has the right to transfer the rights, acquired parties without explicit consent of the Author.
The Author consents that the Article be published under the Creative Commons BY-NC 4.0 (attribution-non-commercial) or comparable licence.
